Note: access to full text and additional information may be available by clicking on the highlighted date.
6/27/2012 – “High Points and Hurdles: Immunotherapy Moves Forward” by Anita T. Shaffer of OncLive
5/7/2012 – “Insight: Training immune system to fight cancer comes of age” by Bill Berkrot of Reuters
3/2/2012 – “Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex’s Crash” by By Adam Feuerstein of TheStreet.com
2/27/2012 – “Dendreon Shares Drop on Slowing Sales of Cancer Vaccine Provenge” by Brett Chase of Minyanville
1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville
1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters
10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal
10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters
8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville
8/22/2011 – “With Dendreon Humbled, Lessons Learned For Cancer Vaccine Makers” by Emily Hayes of The Pink Sheet
8/17/2011 – “Daiichi Sankyo is poster company for sector ripe for M&A” by David Holley of The Deal Pipeline
8/4/2011 – “Dendreon plunges as Provenge prospects wither” by by Bill Berkrot of Reuters
8/4/2011 – “Dendreon’s Stock Plunges on Low Provenge Sales” by Brett Chase of Minyanville
6/30/2011 – “Medicare to cover Dendreon’s prostate drug” by Anna Yukhananov of Reuters
5/17/2011 – “Vical, Exelixis Surge as Cancer Meeting Nears” by Brett Chase of Minyanville
4/25/2011 – “Survivor, biotech” by David Holley of The Deal LLC
Secret to biotech success: luck from The Deal on Vimeo.
3/25/2011 – “Bristol-Myers’ Skin Cancer Drug Gets FDA Nod” by Brett Chase of Minyanville
3/11/2011 – “Copying Dendreon” by Brett Chase of Minyanville
2/27/2011 – “Analysis: Genzyme money seen flowing to other take-out targets” by Bill Berkrot of Reuters
2/7/2011 – “Betting Wrong on the FDA” by Brett Chase of Minyanville
2/4/2011 – “Analysis: The FDA casino and the high rollers of health funds” by Lisa Richwine and Daniel Bases of Reuters
November 2010 – MD Becker Partners listed as featured growth company in Pennsylvania online business magazine Keystone Edge
11/5/2010 – “Pharma Ramps Up Research On Vaccines To Treat Cancer” By Peter Benesh of Investor’s Business Daily
